 |
|
Gains in access to antiretroviral treatment come with some costs
April 28, 2009In this week's PLoS Medicine magazine, Yibeltal Assefa, from the National HIV/AIDS Prevention and Control Office in Addis Ababa, and colleagues describe the successes and challenges of the scale-up of antiretroviral treatment (ART) across Ethiopia.
They report remarkable achievements in expansion of access to ART and to HIV counseling and testing (HCT), while managing to maintain the performance of other health programs such as tuberculosis and maternal and child health services. Task shifting to the health officers and health extension workers is thought to be responsible for these successes, say the authors.
At the same time, however, HIV prevention interventions and the management of chronic care patients are lagging behind now in Ethiopia. The authors say this may be due to lack of attention to these health care areas and to physicians leaving the public sector for non-governmental organizations (NGOs), including AIDS-related NGOs. They say urgent attention is needed in the areas of HIV prevention, management of chronic care patients, and retention of doctors in the public sector to ensure an effective and sustainable health system in Ethiopia.
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.1000056
Public Library of Science
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.1000056
Public Library of Science
Antiretroviral Treatment Current Events and Antiretroviral Treatment News RSSMaternal HIV-1 treatment protects against transmission to newborns
Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding.
Study highlights HIV/AIDS challenge in American prison system
HIV/Aids is up to five times more prevalent in American prisons than in the general population. Adherence to treatment programs can be strictly monitored in prison.
HIV integrase inhibitor effective for patients beginning antiretroviral treatment
A member of a new class of antiretroviral drugs is safe and effective for patients beginning treatment against HIV, according to researchers who have completed a two-year multisite phase III clinical trial comparing it with standard antiretroviral drugs.
AIDS patients with serious complications benefit from early retroviral use, Stanford study shows
HIV-positive patients who don't seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on.
Herpes medication does not reduce risk of HIV transmission
A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.
If started early, HIV treatment reduces death rates toward background levels in African countries
Mortality rates of people starting HIV treatment in four African countries approach those of the general population over time, provided that treatment is started before the immune system has been severely damaged, according to research published this week in the open-access journal PLoS Medicine.
Early administration of antiretroviral therapy can improve survival
The first antiretroviral treatments appeared in 1996. Since then, new and better drugs have been discovered that have almost turned AIDS into a chronic disease.
IL-2 immunotherapy fails to benefit HIV-infected individuals already taking antiretrovirals
Providing a synthetic form of the immune system protein interleukin-2 (IL-2) to HIV-infected individuals already taking combination antiretroviral therapy boosts their numbers of CD4+ T cells, the key white blood cells destroyed by HIV, but fails to reduce their risk of HIV-associated opportunistic diseases or death compared with combination antiretroviral therapy alone.
Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment
Episodic treatment of HIV/AIDS with antiretroviral drugs increases the overall risk of death when compared with continuous antiretroviral treatment (ART), but the reasons why have been unknown.
HIV drug maraviroc effective for drug-resistant patients
As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death.
More Antiretroviral Treatment Current Events and Antiretroviral Treatment News Articles
|
Examining the rollout of pediatric antiretroviral treatment in South Africa.(HIV AND AIDS): An article from: Population Briefs by Gale Reference Team (Author) This digital document is an article from Population Briefs, published by Thomson Gale on May 1, 2007. The length of the article is 1717 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Examining the rollout of pediatric antiretroviral treatment in South Africa.(HIV AND AIDS) Author: Gale Reference Team Publication: Population Briefs (Magazine/Journal) Date: May 1, 2007 Publisher: Thomson Gale Volume: 13 Issue: 1 Page: 4(2) Distributed by Thomson... | |
 |
Thing With No Name Starring: Danisile; Ntombeleni Directed By: Sarah Friedland Also With: Sarah Friedland (Producer), Sarah Friedland (Writer) |
 |
AIDS in Africa Also With: MacNeil / Lehrer Productions (Producer) The AIDS crisis in Africa is the subject of this 2001 NewsHour series. Correspondents report on the situation in three countries: Malawi, Botswana and Senegal. Also included is a discussion about the international community's role in combating the epidemic. A warning: segments in the series contain strong images and frank conversations about sexual habits. |
 |
From access to adherence: The challenges of antiretroviral treatment by A., et al., Davey, S., Gerrits, T., Hodgkin, C. Hardon (Author) As access to ARVs becomes assured, the world needs to place equal effort in ensuring that every ART patient receives adequate adherence support. The authors of this book report on the experiences from successful treatment programmes in three countries in sub-Saharan Africa at the forefront of the roll-out of ARVs. The voices of the patients, their families, community members and the health workers who care for them have been reported faithfully. They speak of the impact of ART on their daily lives and of the key challenges involved in sustaining the necessary high level of adherence to treatment. Their real life experience is valid and needs to be considered by health programme managers who are planning the expansion of ARV treatment programmes. |
|
Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand (1).: An article from: Emerging Infectious Diseases by Somsak Akksilp (Author), Opart Karnkawinpong (Author), Wanpen Wattanaamornkiat (Author), Daranee Viriyakitja (Author), Patama Monkongdee (Author), Walya Sitti (Author), Dhanida Rienthong (Author), Taweesap Siraprapasiri (Author), Charles D. Wells (Author), Jordan W. Tappero (Author), Jay K. Varma (Author) This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on July 1, 2007. The length of the article is 5879 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand (1). Author: Somsak Akksilp Publication: Emerging Infectious Diseases (Magazine/Journal) Date: July 1, 2007 Publisher: Thomson Gale Volume: 13 Issue: 7 Page: 1001(7) Distributed by Thomson... | |
|
Guidance Modules on Antiretroviral Treatments by World Health Organization (Author) | |
|
Provider relationship key in HIV Rx adherence: substance abusers on HAART. (drug treatment, highly active antiretroviral treatment).(Adult Psychiatry): An article from: Clinical Psychiatry News by Damian McNamara (Author) This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on September 1, 2003. The length of the article is 1540 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Provider relationship key in HIV Rx adherence: substance abusers on HAART. (drug treatment, highly active antiretroviral treatment).(Adult Psychiatry) Author: Damian McNamara Publication: Clinical Psychiatry News (Magazine/Journal) Date: September 1, 2003 Publisher: International Medical News Group Volume: 31 Issue: 9 Page: 25(1) Distributed... | |
|
The imperative to treat: the South African State's Constitutional obligations to provide antiretroviral medicines.: An article from: Health Law Review by Lisa Forman (Author) This digital document is an article from Health Law Review, published by Health Law Institute on December 22, 2003. The length of the article is 5066 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: The imperative to treat: the South African State's Constitutional obligations to provide antiretroviral medicines. Author: Lisa Forman Publication: Health Law Review (Magazine/Journal) Date: December 22, 2003 Publisher: Health Law Institute Volume: 12 Issue: 1 Page: 9(7) Distributed by Thomson... | |
|
Panel releases updated HIV treatment guidelines.(Across Specialties): An article from: Clinical Psychiatry News by Sharon Worcester (Author) This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on November 1, 2004. The length of the article is 640 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Panel releases updated HIV treatment guidelines.(Across Specialties) Author: Sharon Worcester Publication: Clinical Psychiatry News (Magazine/Journal) Date: November 1, 2004 Publisher: International Medical News Group Volume: 32 Issue: 11 Page: 63(1) Distributed by Thomson... | |
|
Skin still provides helpful HIV treatment clues. (Much has Changed with HAART).: An article from: Family Practice News by Robert Finn (Author) This digital document is an article from Family Practice News, published by International Medical News Group on April 15, 2003. The length of the article is 616 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Skin still provides helpful HIV treatment clues. (Much has Changed with HAART). Author: Robert Finn Publication: Family Practice News (Magazine/Journal) Date: April 15, 2003 Publisher: International Medical News Group Volume: 33 Issue: 8 Page: 17(1) Distributed by Thomson... |
| © 2009 BrightSurf.com |